Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

What is the optimal number of chemo cycles for advanced urothelial carcinoma?

30 Nov 2018

It appears that four cycles of platinum-based, first-line chemotherapy are tolerable and do not significantly compromise the survival of patients with metastatic urothelial carcinoma, suggests a study.

A total of 1,020 patients were included, of whom 338 and 134 received cisplatin or carboplatin, respectively. Three to five cycles (median, four) of chemotherapy were given to 157 patients, while 315 received six to nine cycles (median, six).

Overall survival between the two cycles did not show any significant difference (hazard ratio, 1.02; 95 percent CI, 0.78–1.3; p=0.91). Moreover, there were no significant interactions for the type of platinum (p=0.09) and completed planned chemotherapy (p=0.56).

Limitations of a hypothesis-generating, retrospective analysis applied.

“The omission of excessive cycles may avoid unnecessary cumulative toxicity and facilitate a better transition to second line therapy and investigational switch maintenance therapy strategies,” the authors said. “These results require prospective validation, but they may impact practice in select patients.”

The RISC (Retrospective International Study of Invasive/Advanced Cancer of the Urothelium) database was accessed to identify patients in this study. The authors performed Cox multiple regression analysis, controlling for recognized prognostic factors, to examine the association between the number of cycles of chemotherapy and overall survival.

Patients who received fewer than three or more than nine platinum chemotherapy cycles were excluded to reduce confounding factors. Overall survival for three to five and six to nine cycles was the primary endpoint, using 6-month landmark analysis when 281 death events occurred.

Editor's Recommendations
Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.